Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

Similar articles for PubMed (Select 21164527)

1.

The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors.

Koup RA, Graham BS, Douek DC.

Nat Rev Immunol. 2011 Jan;11(1):65-70. doi: 10.1038/nri2890. Epub 2010 Dec 17.

PMID:
21164527
2.

Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine.

Haut LH, Ertl HC.

J Leukoc Biol. 2009 Oct;86(4):779-93. doi: 10.1189/jlb.0209094. Epub 2009 Jul 13. Review.

3.

Vaccines and vaccine strategies against HIV.

Stratov I, DeRose R, Purcell DF, Kent SJ.

Curr Drug Targets. 2004 Jan;5(1):71-88. Review.

PMID:
14738219
4.

Recent advances in the development of HIV-1 Tat-based vaccines.

Caputo A, Gavioli R, Ensoli B.

Curr HIV Res. 2004 Oct;2(4):357-76. Review.

PMID:
15544457
5.

HIV preventive vaccines. Progress to date.

Esparza J, Osmanov S, Heyward WL.

Drugs. 1995 Nov;50(5):792-804. Review.

PMID:
8586027
6.

T cell immune responses to HIV-1.

Vasan S, Schlesinger SJ, Arrode G.

Front Biosci. 2007 Jan 1;12:2330-43. Review.

PMID:
17127243
7.

HIV vaccine development at the turn of the 21st century.

Girard MP, Plotkin SA.

Curr Opin HIV AIDS. 2012 Jan;7(1):4-9. doi: 10.1097/COH.0b013e32834ddc96. Review.

PMID:
22156840
8.

Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.

Girard MP, Osmanov S, Assossou OM, Kieny MP.

Vaccine. 2011 Aug 26;29(37):6191-218. doi: 10.1016/j.vaccine.2011.06.085. Epub 2011 Jun 28. Review.

PMID:
21718747
9.

HIV-1 vaccine clinical trials: the Brazilian experience.

Ersching J, Pinto AR.

Rev Med Virol. 2009 Sep;19(5):301-11. doi: 10.1002/rmv.625.

PMID:
19650156
10.

HIV vaccines: a global perspective.

Esparza J, Osmanov S.

Curr Mol Med. 2003 May;3(3):183-93. Review.

PMID:
12699356
11.

The prospects for vaccines against HIV-1: more than a field of long-term nonprogression?

Sheppard N, Sattentau Q.

Expert Rev Mol Med. 2005 Feb 8;7(2):1-21. Review.

PMID:
15710051
12.

Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.

Nehete PN, Chitta S, Hossain MM, Hill L, Bernacky BJ, Baze W, Arlinghaus RB, Sastry KJ.

Vaccine. 2001 Dec 12;20(5-6):813-25.

PMID:
11738745
13.

AIDS vaccine development: the long and winding road.

Garber DA, Feinberg MB.

AIDS Rev. 2003 Jul-Sep;5(3):131-9. Review.

PMID:
14598562
14.

Predictive value of primate models for AIDS.

Haigwood NL.

AIDS Rev. 2004 Oct-Dec;6(4):187-98. Review.

PMID:
15700617
15.

Biological considerations in the development of a human immunodeficiency virus vaccine.

Nathanson N, Mathieson BJ.

J Infect Dis. 2000 Aug;182(2):579-89. Epub 2000 Jul 28. Review.

16.

Particle-based vaccines for HIV-1 infection.

Young KR, Ross TM.

Curr Drug Targets Infect Disord. 2003 Jun;3(2):151-69. Review.

PMID:
12769792
17.
19.

Strategies for AIDS vaccines.

Stott EJ, Schild GC.

J Antimicrob Chemother. 1996 May;37 Suppl B:185-98. Review.

20.

Defining the protective antibody response for HIV-1.

Mascola JR.

Curr Mol Med. 2003 May;3(3):209-16. Review.

PMID:
12699358
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk